AOD-9604 stimulates fat breakdown (fat decomposition or destruction) and inhibits fat generation (preventing food materials rich in fat from being converted into body fat)
You Do Not Sell Or Use Our Content Commercially Our work is free to share, but it may not be sold, monetized, or repurposed for commercial gain
A consultation with our medical team is required to determine if these therapies are appropriate for you.
References (1) Pissios P
Grimm M-J, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Meissner WG, Nilsson C, Piot I, Compta Y, Rowe JB, Group for the MDS-EPS (2020) Clinical conditions Suggestive of Progressive Supranuclear PalsyDiagnostic Performance
Abbreviations A: Amyloid beta AD: Alzheimers disease ADDF: Alzheimers Drug Discovery Foundation ADRD: Alzheimers disease and related dementias CDR: Clinical Dementia Rating CNS: Central nervous system CSF: Cerebrospinal fluid COX-2: Cyclooxygenase 2 D: Dasatinib D+Q: Senolytic therapy including the combination of Dasatinib and Quercetin FDA: Food and Drug Administration FOXO4: Forkhead box protein O4 FOXO4-DRI: FOXO4-D-Retro-Inverso PET: Positron emission tomography MAPK: Mitogen-activated protein kinas MDM2: Murine double minute 2 mTOR: Mammalian target of rapamycin MRI: Magnetic resonance imaging NFT: Neurofibrillary tangle OPC: Oligodendrocyte precursor cell PI3Kd: Phosphatidylinositol 3-kinase-delta PL: Piperlongumine Q: Quercetin ROS: Reactive oxygen species SToMP-AD: Senolytic Therapy to Modulate the Progression of Alzheimers Disease, acronym for clinical trial USP7: Ubiquitin-specific peptidase 7 TBI: Traumatic brain injury uPAR: Urokinase-type plasminogen activator receptor WAT: White adipose tissue References Mehegan, L., and Chuck Rainville
